Command Palette

Search for a command to run...

Clinical Trials · NCT03856047

Research Study Investigating How Well NNC0174-0833 Works in People Suffering From Overweight or Obesity.

CompletedPhase 2Cagrilintide (Approved)
Phase
Phase 2
Recruitment status
Completed
Sponsor
Novo Nordisk A/S
Enrollment
706
Start date
Mar 2019
Locations
54 sites, 10 countries
Primary endpoint
Change in Body Weight (%)
View Cagrilintide compound reference